CRDL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cardiol Therapeutics Inc (CRDL) is not a strong buy for a beginner, long-term investor at this time. The lack of positive financial performance, absence of significant trading trends, and no recent news or catalysts make it a less compelling investment. Additionally, technical indicators and options data do not suggest a strong bullish sentiment.
The MACD histogram is positive and expanding, indicating a slight bullish momentum. RSI is at 68.544, which is neutral and does not indicate overbought or oversold conditions. Moving averages are converging, showing no clear trend. Key resistance levels are at 1.074 and 1.1, while support levels are at 0.99 and 0.964.
No significant positive catalysts identified. MACD shows slight bullish momentum.
Financial performance is weak with declining net income (-21.72% YoY) and EPS (-33.33% YoY). No recent news, trading trends, or significant insider or hedge fund activity. Congress trading data is also absent.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -9,964,281 (-21.72% YoY), and EPS fell to -0.12 (-33.33% YoY). Gross margin remained at 0 with no change.
No data available for analyst ratings or price target changes.
